ANTX
AN2 Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD4.20
+0.13 (+3.19%)
Rating:C
Company Profile
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$4.10
Prev. Close
$4.07
Day Low
$4.04
Day High
$4.32
52W Low
$1.00
52W High
$6.91
Market Cap
$0.12B
Volume
0.21M